Table 8.
Clinical Stage (UICC TNM 7th)
| Clinical stage | Endoscopic treatment (%) | Surgery | Chemotherapy and/or radiotherapy | Total (%) | |||||
|---|---|---|---|---|---|---|---|---|---|
| Esophagectomy (%) | Palliative surgery (%) | CRT (%) | RT alone (%) | Chemotherapy alone (%) | Palliative RT (%) | Others (%) | |||
| Stage IA | 1557 (91.1%) | 1291 (25.0%) | 5 (2.7%) | 175 (14.5%) | 70 (21.2%) | 12 (2.7%) | 4 (3.6%) | 234 (7.7%) | 3126 (33.4%) |
| Stage IB | 10 (0.6%) | 448 (8.7%) | 3 (1.6%) | 36 (3.0%) | 15 (4.5%) | 17 (3.8%) | 8 (7.1%) | 235 (7.8%) | 548 (5.8%) |
| Stage IIA | 6 (0.4%) | 537 (10.4%) | 5 (2.7%) | 62 (5.1%) | 25 (7.6%) | 17 (3.8%) | 7 (6.3%) | 324 (10.7%) | 661 (7.1%) |
| Stage IIB | 19 (1.1%) | 568 (11.0%) | 2 (1.1%) | 63 (5.2%) | 31 (9.4%) | 22 (4.9%) | 3 (2.7%) | 353 (11.7%) | 715 (7.6%) |
| Stage IIIA | 21 (1.2%) | 1146 (22.2%) | 30 (16.5%) | 136 (11.3%) | 50 (15.2%) | 51 (11.3%) | 20 (17.9%) | 858 (28.4%) | 1454 (15.5%) |
| Stage IIIB | 9 (0.5%) | 575 (11.1%) | 20 (11.0%) | 96 (8.0%) | 18 (5.5%) | 31 (6.9%) | 16 (14.3%) | 434 (14.4%) | 758 (8.1%) |
| Stage IIIC | 30 (1.8%) | 391 (7.6%) | 68 (37.4%) | 322 (26.7%) | 49 (14.8%) | 61 (13.6%) | 26 (23.2%) | 370 (12.3%) | 992 (10.6%) |
| Stage IV | 29 (1.7%) | 196 (3.8%) | 49 (26.9%) | 310 (25.7%) | 64 (19.4%) | 232 (51.6%) | 26 (23.2%) | 206 (6.8%) | 998 (10.7%) |
| Unknown | 28 (1.6%) | 20 (0.4%) | 0 (0.0%) | 7 (0.6%) | 8 (2.4%) | 7 (1.6%) | 2 (1.8%) | 6 (0.2%) | 116 (1.2%) |
| Total | 1709 | 5172 | 182 | 1207 | 330 | 450 | 112 | 3020 | 9368 |